Skip to main content

Advertisement

Log in

Will Availability of SMOF Lipid Emulsions for Parenteral Nutrition Change Surgical Nutrition Practice?

  • Gastroenterology, Critical Care, and Lifestyle Medicine (SA McClave, Section Editor)
  • Published:
Current Nutrition Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Parenteral nutrition (PN) is a widely accepted form of nutrition administration in patients in whom enteral feeding is contraindicated or insufficient. This is true in surgical patient populations, as well. As a component of PN, intravenous fat emulsions (IVFEs) are essential for the administration of essential fatty acids (EFAs) and adequate energy intake. The oils that make up standard IVFE formulations have evolved over time.

Recent Findings

A newer formulation, known as SMOF, contains a combination of soybean oil, medium chain triglycerides, olive oil, and fish oil and is gaining popularity for its purported beneficial effects on liver function, inflammation, and anti-oxidant status.

Summary

This literature review examines the current data regarding the effects of SMOF in the patient receiving PN and examines the role SMOF may play in the future management of nutrition in the surgical population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Vassilyadi F, Panteliadou AK, Panteliadis C. Hallmarks in the history of enteral and parenteral nutrition: from antiquity to the 20th century. Nutr Clin Pract. 2013;28(2):209–17.

    Article  PubMed  Google Scholar 

  2. • Anez-Bustillos L, Dao DT, Baker MA, Fell GL, Puder M, Gura KM. Intravenous fat emulsion formulations for the adult and pediatric patient: understanding the differences. Nutr Clin Pract. 2016;31(5):596–609. Understanding the metabolic actions of the various lipid components available in PN solutions is foundational to PN administration. This article is an excellent review of the various mixtures and compounds available that make up the lipid component of PN.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications of total parenteral nutrition. Gastroenterology. 1993;104(1):286–301.

    Article  CAS  PubMed  Google Scholar 

  4. Kelly DA. Liver complications of pediatric parenteral nutrition--epidemiology. Nutrition. 1998;14(1):153–7.

    Article  CAS  PubMed  Google Scholar 

  5. Kumpf VJ. Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr Clin Pract. 2006;21(3):279–90.

    Article  PubMed  Google Scholar 

  6. Squires RH, Duggan C, Teitelbaum DH, et al. Natural history of pediatric intestinal failure: initial report from the pediatric intestinal failure consortium. J Pediatr. 2012;161(4):723–8. e722

    Article  PubMed  PubMed Central  Google Scholar 

  7. Nandivada P, Fell GL, Gura KM, Puder M. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children. Am J Clin Nutr. 2016;103(2):629S–34S.

    Article  CAS  PubMed Central  Google Scholar 

  8. Messing B, Bories C, Kunstlinger F, Bernier JJ. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology. 1983;84(5 Pt 1):1012–9.

    CAS  PubMed  Google Scholar 

  9. Calder PC. Functional roles of fatty acids and their effects on human health. JPEN. J Parenter Enter Nutr. 2015;39(1 Suppl):18S–32S.

    Article  Google Scholar 

  10. Shinohara M, Mirakaj V, Serhan CN. Functional metabolomics reveals novel active products in the DHA metabolome. Front Immunol. 2012;3:81.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Serhan CN, Dalli J, Colas RA, Winkler JW, Chiang N. Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim Biophys Acta. 2015;1851(4):397–413.

    Article  CAS  PubMed  Google Scholar 

  12. Fell GL, Nandivada P, Gura KM, Puder M. Intravenous lipid emulsions in parenteral nutrition. Adv Nutr. 2015;6(5):600–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr. 1997;66(3):683–706.

    CAS  Google Scholar 

  14. Villet S, Chiolero RL, Bollmann MD, et al. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr. 2005;24(4):502–9.

    Article  PubMed  Google Scholar 

  15. Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365(6):506–17.

    Article  CAS  PubMed  Google Scholar 

  16. de Aguilar-Nascimento JE, Bicudo-Salomao A, Portari-Filho PE. Optimal timing for the initiation of enteral and parenteral nutrition in critical medical and surgical conditions. Nutrition. 2012;28(9):840–3.

    Article  PubMed  Google Scholar 

  17. Souba WW. Nutritional support. N Engl J Med. 1997;336(1):41–8.

    Article  CAS  PubMed  Google Scholar 

  18. Sandstrom R, Drott C, Hyltander A, et al. The effect of postoperative intravenous feeding (TPN) on outcome following major surgery evaluated in a randomized study. Ann Surg. 1993;217(2):185–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Grimble RF. Dietary lipids and the inflammatory response. Proc Nutr Soc. 1998;57(4):535–42.

    Article  CAS  Google Scholar 

  20. Jolliet P, Pichard C. Immunonutrition in the critically ill. Intensive Care Med. 1999;25(6):631–3.

    Article  CAS  PubMed  Google Scholar 

  21. Santos JI. Nutrition, infection, and immunocompetence. Infect Dis Clin N Am. 1994;8(1):243–67.

    CAS  Google Scholar 

  22. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M, Milla PJ. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology. 1993;105(6):1806–13.

    Article  CAS  Google Scholar 

  23. Iyer KR, Spitz L, Clayton P. BAPS prize lecture: new insight into mechanisms of parenteral nutrition-associated cholestasis: role of plant sterols. British Association of Paediatric Surgeons. J Pediatr Surg. 1998;33(1):1–6.

    Article  CAS  PubMed  Google Scholar 

  24. Ulrich H, Pastores SM, Katz DP, Kvetan V. Parenteral use of medium-chain triglycerides: a reappraisal. Nutrition. 1996;12(4):231–8.

    Article  CAS  PubMed  Google Scholar 

  25. Mok KT, Maiz A, Yamazaki K, et al. Structured medium-chain and long-chain triglyceride emulsions are superior to physical mixtures in sparing body protein in the burned rat. Metab Clin Exp. 1984;33(10):910–5.

    Article  CAS  PubMed  Google Scholar 

  26. Baldermann H, Wicklmayr M, Rett K, Banholzer P, Dietze G, Mehnert H. Changes of hepatic morphology during parenteral nutrition with lipid emulsions containing LCT or MCT/LCT quantified by ultrasound. JPEN. J Parenter Enter Nutr. 1991;15(6):601–3.

    Article  CAS  Google Scholar 

  27. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition. 1998;14(1):158–64.

    Article  CAS  PubMed  Google Scholar 

  28. Savini S, D'Ascenzo R, Biagetti C, et al. The effect of 5 intravenous lipid emulsions on plasma phytosterols in preterm infants receiving parenteral nutrition: a randomized clinical trial. Am J Clin Nutr. 2013;98(2):312–8.

    Article  CAS  PubMed  Google Scholar 

  29. Vlaardingerbroek H, Vermeulen MJ, Carnielli VP, Vaz FM, van den Akker CH, van Goudoever JB. Growth and fatty acid profiles of VLBW infants receiving a multicomponent lipid emulsion from birth. J Pediatr Gastroenterol Nutr. 2014;58(4):417–27.

    Article  CAS  PubMed  Google Scholar 

  30. Antebi H, Mansoor O, Ferrier C, et al. Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsions. JPEN. J Parenter Enter Nutr. 2004;28(3):142–8.

    Article  CAS  Google Scholar 

  31. •• Klek S, Chambrier C, Singer P, et al. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)--a double-blind, randomised, multicentre study in adults. Clin Nutr. 2013;32(2):224–31. PRCT of 73 patients comparing a SMOF mixture versus standard intralipid, patients were given 4 weeks of each. SMOF group demonstrated improvement in liver function tests, as well as improved lipid profiles when compared with control group. Study demonstrated longer term safety in use of the SMOF formulas.

    Article  CAS  PubMed  Google Scholar 

  32. •• Rayyan M, Devlieger H, Jochum F, Allegaert K. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants. JPEN J Parenter Enteral Nutr. 2012;36(1 Suppl):81S–94S. Double blinded RCT comparing greater than 7 days of PN with soybean oil versus SMOF in preterm infants requiring PN. Statisitically significant reduction was seen in the SMOF group in total and direct bilirubin, as well as significant improvement overall fatty acid profiles, when compared with the soybean group.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Tomsits E, Pataki M, Tolgyesi A, Fekete G, Rischak K, Szollar L. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010;51(4):514–21.

    Article  CAS  PubMed  Google Scholar 

  34. Goulet O, Antebi H, Wolf C, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN. J Parenter Enter Nutr. 2010;34(5):485–95.

    Article  CAS  Google Scholar 

  35. Grimm H, Tibell A, Norrlind B, Blecher C, Wilker S, Schwemmle K. Immunoregulation by parenteral lipids: impact of the n-3 to n-6 fatty acid ratio. JPEN J Parenter Enter Nutr. 1994;18(5):417–21.

    Article  CAS  Google Scholar 

  36. Simopoulos AP, Leaf A, Salem N Jr. Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metab. 1999;43(2):127–30.

    Article  CAS  PubMed  Google Scholar 

  37. Kinsella JE, Broughton KS, Whelan JW. Dietary unsaturated fatty acids: interactions and possible needs in relation to eicosanoid synthesis. J Nutr Biochem. 1990;1(3):123–41.

    Article  CAS  PubMed  Google Scholar 

  38. Grimm H, Mertes N, Goeters C, et al. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr. 2006;45(1):55–60.

    Article  CAS  PubMed  Google Scholar 

  39. Ma CJ, Sun LC, Chen FM, et al. A double-blind randomized study comparing the efficacy and safety of a composite vs a conventional intravenous fat emulsion in postsurgical gastrointestinal tumor patients. Nutr Clin Pract. 2012;27(3):410–5.

    Article  PubMed  Google Scholar 

  40. Wu MH, Wang MY, Yang CY, Kuo ML, Lin MT. Randomized clinical trial of new intravenous lipid (SMOFlipid 20%) versus medium-chain triglycerides/long-chain triglycerides in adult patients undergoing gastrointestinal surgery. JPEN. J Parenter Enter Nutr. 2014;38(7):800–8.

    Article  CAS  Google Scholar 

  41. Linseisen J, Hoffmann J, Lienhard S, Jauch KW, Wolfram G. Antioxidant status of surgical patients receiving TPN with an omega-3-fatty acid-containing lipid emulsion supplemented with alpha-tocopherol. Clin Nutr. 2000;19(3):177–84.

    Article  CAS  PubMed  Google Scholar 

  42. Skouroliakou M, Konstantinou D, Koutri K, et al. A double-blind, randomized clinical trial of the effect of omega-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr. 2010;64(9):940–7.

    Article  CAS  Google Scholar 

  43. Jones CJ, Calder PC. Influence of different intravenous lipid emulsions on fatty acid status and laboratory and clinical outcomes in adult patients receiving home parenteral nutrition: a systematic review. Clin Nutr. 2016.

  44. Wanten GJ, Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr. 2007;85(5):1171–84.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew C. Bozeman.

Ethics declarations

Conflict of Interest

Elizabeth H. Cameron, Neal Bhutiani, and Matthew C. Bozeman declare they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Gastroenterology, Critical Care, and Lifestyle Medicine

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cameron, E.H., Bhutiani, N. & Bozeman, M.C. Will Availability of SMOF Lipid Emulsions for Parenteral Nutrition Change Surgical Nutrition Practice?. Curr Nutr Rep 6, 266–273 (2017). https://doi.org/10.1007/s13668-017-0215-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13668-017-0215-9

Keywords

Navigation